| III-019 Anna Mc Laughlin Model-informed early clinical development of BI-1808, a novel monoclonal antibody to tumor necrosis factor receptor 2 Thursday 09:50-11:20 |
| III-019 Anna Mc Laughlin Model-informed early clinical development of BI-1808, a novel monoclonal antibody to tumor necrosis factor receptor 2 Thursday 09:50-11:20 |